Literature DB >> 343970

Gastrointestinal microbleeding after aspirin and naproxen.

A Lussier, A Arsenault, J Varady.   

Abstract

Gastrointestinal bleeding is the most serious side effect encountered with the anti-inflammatory antirheumatic drugs. Using the 51Cr labeling technique, the comparative quantity of blood loss with aspirin or naproxen has been previously done on normal volunteers. With the present study, 12 rheumatoid arthritic patients were controlled in a double-blind crossover study with the same radioactive technique. There is a difference in favor of naproxen. The difference between the baseline period and naproxen administration was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343970     DOI: 10.1002/cpt1978234402

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents.

Authors:  R E Pemberton; L J Strand
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

2.  Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Drug Metab Dispos       Date:  2017-02-28       Impact factor: 3.922

3.  Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?

Authors:  P Dandona; J Y Jeremy
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen.

Authors:  Xiaonan Li; Debra C DuBois; Dawei Song; Richard R Almon; William J Jusko; Xijing Chen
Journal:  Drug Metab Dispos       Date:  2017-04-17       Impact factor: 3.922

Review 5.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

Review 6.  Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.

Authors:  F L Lanza; J D Arnold
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.